Automation and customization solutions include scientists and engineers who can customize our instruments, as well as automate entire workflows to meet the specific needs of your assay, method, or protocol. We take a consultative approach to understand your application requirements and recommend labware, lab robotics, and software solutions that best match the unique needs of your application.
At the new Organoid Innovation Center at Molecular Devices we showcase these cutting-edge technologies with novel 3D biology methods to address key challenges of scaling complex 3D biology.
No matter the scientific question or application at hand, an automated workflow can bring answers to light, faster. By integrating leading technology from across the industry into a flexible, customizable workcell, researchers can greatly optimize their time in the lab and free up resources for other critical tasks, speeding discovery.
Industry-leading technology from collaborators integrate seamlessly into the workcell, creating a truly end-to-end, automated workflow solution for any lab. From incubators, liquid handlers, and robotics to customized software and hardware—and with over 35 years of experience in the life science industry—you can count on us to deliver quality products and provide worldwide support.
Blog
The Role of CRISPR in Scientific Breakthroughs in Microbiome Engineering Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) was first discovered in the genome of marine…
Blog
We caught up with Laura Dranschak, Director of Commercial Operations & Custom Solutions, to catch up on all things SLAS 2023. See what all the buzz was about on the show floor,…
Scientific Poster
3D bioprinting enables the generation of complex models with spatial control and a variety of matrices allowing the formation of complex tissue structures. Here we describe a method for…
Blog
The drug discovery landscape is changing. Bringing a drug to market has historically been time-consuming and costly, with many candidates failing in the first phase of clinical trials…
Application Note
Many oncology drugs fail at the later stages of the drug development pipeline and in clinical trials, despite promising data for their efficacy in vitro. This high failure rate is…
Scientific Poster
3D organoids are increasingly popular in drug discovery and disease modeling as they better represent biologically relevant microenvironments, tissue architecture, and functionality. Ho…
Scientific Poster
The automation of the 3D cell models results in a significant reduction in the time and effort involved, as well as an increase in assay precision and throughput. Here we describe metho…
Scientific Poster
Organotypic three-dimensional (3D) cultures resemble native 3D tissue architecture and are believed to be more representative of real tissues than their 2D (monolayer) counterparts, thu…
News
SAN JOSE, Calif., and UTRECHT, Netherlands, Feb. 13, 2023 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HUB Organoids (HUB), the pioneer…
Publications
More researchers are using gene editing to build disease models that better represent human tissues' complex biology, signaling a shift away from 2D cell culture or animal models to…
Publications
3DPrint.com, the leading source for actionable intelligence related to 3D printing technology and the larger AM industry, covers our collaboration…
Publications
Following our acquisition of Cellesce Ltd, Tanya Samazan from Instrument Business Outlook dove deep into conversation with Molecular Devices President Susan Murphy and Cellesce CEO V…
News
Turnkey platform integrates flexible robotic automation with high-content imaging of complex 3D cellular models, enabling high-volume organoid screening SAN JOSE, Calif., Jan. 4, 2023…
News
First-of-its-kind technology from Cellesce creates consistent patient-derived organoids for large scale drug screening Acquisition strengthens Molecular Devices’ position as a 3D…
Scientific Poster
Most potential oncology drugs fail the drug development pipeline, despite having promising data for their efficacy in vitro. This further incentivize the need for identifying in vitr…
Scientific Poster
Three-dimensional (3D) cell models that represent various tissues are being successfully used in drug discovery and disease modeling to study complex biological effects and tissue ar…
Publications
We recently partnered with HeartBeat.bio to automate and scale the production of cardioids — 3D cell models of the heart that can more accurately recapitulate human biology.
…
Publications
In April 2021, we launched our Organoid Innovation Centre (OIC), an initiative designed to help scientists leverage the potential of 3D biology throughout the drug discovery process.…
Blog
SLAS Europe 2022, hosted numerous sessions packed with the latest research on emerging topics as well as sessions and panel discussions focused on how to build, and succeed, in a…
News
Larger site will be future home of the Organoid Innovation Center – Salzburg, a collaborative space for advancing automated cell line development, organoid development, and screening…
News
SAN JOSE, Calif., and VIENNA, Sept. 12, 2022 – Molecular Devices, LLC., a leading provider of high-performance life science solutions, and HeartBeat.bio AG, a biotech company…
Blog
It was another great year at ISSCR 2022! Leaders from across the globe came together to discuss new technologies, share insights, and explore the newest breakthroughs in stem cell…
Blog
As your lab’s needs expand, automating every step of an intricate workflow provides exponential value. From increased walk-away time and throughput to reduced human error and improved…
Blog
3D cell models are becoming increasingly popular for studying complex biological effects, tissue functionality, and diseases. Their ability to self-organize and mimic…
Scientific Poster
Multiparametric high-content screening approaches, such as the Cell Painting assay, are increasingly being used in many applications ranging from drug discovery programs to functiona…
Scientific Poster
There is a critical need for biological model systems that better resemble human biology. Three-dimensional (3D) cell models and organ-on-a-chip (OoC) structures representing various…
Scientific Poster
Here we describe a workflow for automation of organoid culture. The automated method utilizes an integrated work-cell, consisting of several instruments providing automated cell cult…
Blog
For three decades, Molecular Devices has made scientific breakthroughs possible for academic, pharmaceutical, government, and biotech customers with its innovative life science…
Flyer
The Organoid Innovation Center showcases cutting-edge instruments that work harmoniously together for autonomous, long-term, 3D and 2D live cell culture growth and monitoring with in…
Blog
SLAS2022, the Society for Lab Automation and Screening conference offered another exciting year for learning about innovative laboratory technologies. Whether you attended in-person…
Scientific Poster
3D cell culture as a model system is increasingly popular because it recapitulates the in vivo microenvironment better than 2D cell cultures. Organoids have the capacity for stable d…
Scientific Poster
Triple negative breast cancer is a clinically aggressive tumor subtype, with high rates of metastasis, recurrence, and drug resistance. Currently there are no clinically approved sma…
Scientific Poster
Image-based phenotypic profiling approaches, such as the widely-used Cell Painting assay, use high-content imaging along with multiparametric readouts to study biological, genetic, a…
Blog
In life sciences, more is more. Obtaining a great body of data that is consistent and insightful to get a qualitative and quantitative overview of your model is critical. However,…
Blog
From customer feedback to workflow improvements The path to understanding complex biological processes and diseases is paved with a lot of challenges. As the desired level of…
Publications
"As the transition from 2D to 3D cell cultures, or organoids, as the gold standard for modeling basic biology and disease continues, these models are being utilized in ever m…
Application Note
We describe an automated integrated system that would allow automated monitoring, maintenance, and characterization of growth and differentiation of organoids and stem cells, as well…
Publications
Lab Manager speaks to Dan O’Connor, vice president, drug discovery, Molecular Devices, about the company’s Organoid Innovation Center in San Jose, CA. The center is 180 sq. ft., with…
Publications
Molecular Devices, a provider of innovative life science technology, recently unveiled a brand new, first-of-its-kind Organoid Innovation Center. Situated at the company’s global hea…
Scientific Poster
Organoid models have increasingly gained popularity in biologic research and screening to recapitulate complexity of real tissues. To model the in vivo human lungs, we have cultured…
Publications
The QPix™ Chroma Filter is a thin film translucent optical filter that provides a robust method to confidently select and pick rare expressing bacterial colonies based on color inten…
Scale Up Your Screening: Integrating Automation Into 3D Biology for Therapeutic Drug Discovery
Using Differentiated iPSCs to Build Ready-to-use 3D Models
The search for answers: Using lab automation with patient-derived tumoroids to find more relevant therapies for clinically aggressive cancers
Ananda Neurite Untangled
3D Imaging Seminar Series
Automate your 3D biology high-throughput workflows
Leverage automated, end-to-end workflows to enable complex organoid assays
Automating culture and high-content imaging of 3D organoids for in vitro assessment of compound effects
Tips to automating molecular cloning and strain engineering applications
Organoid Innovation Center Walkthrough